IL6 and COVID-19: Of the upregulated inflammatory cytokines, IL-6 has been considered as a key cytokine involved in the cytokine storm triggered by COVID-19 and given the high levels of this cytokine induced by SARS-CoV-2, IL-6 blocking agents have been used for treating severe COVID-19.